glp 1 biochemistry GLP-1 Research Peptides: What Labs Need to Know GLP-1 is released from the

Both liraglutide and semaglutide have been shown to reduce obesity-induced muscle atrophy via a GLP-1/Sirtuin (SIRT1) pathway in rodents (40)

If you encounter serious side effects while on GLP-1 treatment, stop using the medication right away and reach out to your healthcare provider

Why It Works: Eliminates triggers like refined carbs that spike hunger, retraining your palate post-GLP-1

These could include: Digestive issues & feeling sick, especially when first starting Possible constipation or diarrhoea Some people experience fatigue Potential risk of thyroid tumors (rare) 2

Oral semaglutide produces modest weight loss of 3-5% of body weight on average, compared to 10-15% with injectable semaglutide (Wegovy) and 15-22% with injectable tirzepatide (Zepbound)